COURTNEY CALANDRO: Open Payments
NPI 1710069455 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,836 in 133 payments from 19 companies in 2025. Trend: 2023 $1,396 · 2024 $2,073 · 2025 $2,836
Food & beverage: $2,752Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $703 |
| Madrigal Pharmaceuticals | 13 | $407 |
| Ardelyx, Inc. | 15 | $317 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $261 |
| Janssen Biotech, Inc. | 5 | $233 |
| PFIZER INC. | 10 | $152 |
| QOL Medical, LLC | 6 | $148 |
| Aimmune Therapeutics, Inc. | 3 | $94 |
| Gilead Sciences, Inc. | 4 | $78 |
| VIVUS LLC | 4 | $76 |
Products named: REZDIFFRA, IBSRELA, VIBERZI, TREMFYA, ENTYVIO, CREON, Sucraid, SKYRIZI.
Industry payments across CT — which companies pay providers there.
